Global Rapid Test Kits Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2021 growth of Rapid Test Kits will have significant change from previous year. By the most conservative estimates of global Rapid Test Kits market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rapid Test Kits market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Test Kits market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Over-the-counter (OTC) Rapid Test Product
Professional Rapid Test Product

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Infectious Disease
Cardiology
Oncology
Pregnancy and Fertility
Toxicology
Glucose Monitoring
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Becton, Dickinson and Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Akers Biosciences, Inc.
Abbott
Cepheid, Inc.
Hologic, Inc.
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Quidel Corporation
Roche Diagnostics
Creative Diagnostics
Cardinal Health
RayBiotech
Guangzhou Wondfo Biotech
Sinocare
Maccura Biotechnology Co